T0	Outcomes 29 48	efficacy and safety
T1	Outcomes 757 794	was in-segment binary restenosis rate
T2	Outcomes 854 1056	included target vessel failure (TVF; including cardiac death, myocardial infarction, and target vessel revascularization) and Academic Research Consortium-defined definite/probable stent thrombosis (ST)
T3	Outcomes 1139 1147	endpoint
T4	Outcomes 1389 1400	the rate of